Treatment with IFN-α,-β,or-γ is associated with collapsing focal segmental glomerulosclerosis

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 4, 2010, Pages 607-615

  Markowitz, Glen S ^a   Nasr, Samih H ^a   Stokes, M Barry ^a   D'Agati, Vivette D ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA1A INTERFERON; GAMMA INTERFERON; INTERFERON BETA SERINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FEMALE; FIBROSING ALVEOLITIS; FOCAL GLOMERULOSCLEROSIS; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; KIDNEY BIOPSY; KIDNEY FUNCTION; MALE; MELANOMA; MULTIPLE SCLEROSIS; PROTEIN URINE LEVEL; TREATMENT OUTCOME; VIRUS HEPATITIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOPSY; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HEPATITIS C; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; KIDNEY; KIDNEY FAILURE, ACUTE; MALE; MELANOMA; MIDDLE AGED; MULTIPLE SCLEROSIS; PROTEINURIA; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 77950919863     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07311009     Document Type: Article

References (59)

1. D'Agati V: The spectrum of focal segmental glomerulosclerosis: New insights. Curr Opin Nephrol Hypertens 17: 271-281, 2008 (Pubitemid 351535930)
2. Haas M, Spargo BH, Coventry S: Increasing incidence of focal segmental glomerulosclerosis among adult nephropathies: A 20-year renal biopsy study. Am J Kidney Dis 26: 740-750, 1995
3. Korbet SM, Genchi R, Borok RZ, Schwartz MM: The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27: 647-651, 1996 (Pubitemid 26135836)
4. Haas M, Meehan SM, Karrision TG, Spargo BH: Changing etiologies of unexplained nephrotic adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis 30: 621-631, 1997 (Pubitemid 27465355)
5. Kitiyakara C, Eggers P, Kopp JB: Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44: 815-825, 2004 (Pubitemid 39445913)
6. Nair R, Walker PD: Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney Int 69: 1455-1458, 2006
7. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC: Pathologic classification of FSGS: A working proposal. Am J Kidney Dis 43: 368-382, 2004
8. Stokes MB, Valeri AM, Markowitz GS, D'Agati VD: Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int 70: 1783-1792, 2006 (Pubitemid 44684810)
9. Thomas DB, Franceschini N, Hogan SL, ten Holder S, Jennette CE, Falk RJ, Jennette JC: Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 69: 920-926, 2006
10. Weiss MA, Daquioag E, Margolin EG, Pollak VE: Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": A new clinicopathologic entity? Am J Kidney Dis 7: 20-28, 1986 (Pubitemid 16157415)
11. Valeri A, Barisoni L, Appel GB, Seigle R, D'Agati V: Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study. Kidney Int 50: 1734-1746, 1996 (Pubitemid 26364283)
12. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis. Kidney Int 45: 1416-1424, 1994
13. D'Agati VD, Suh J, Carbone L, Appel GB: The pathology of HIV-associated nephropathy: A detailed morphologic and comparative study. Kidney Int 35: 1358-1370, 1989 (Pubitemid 19167929)
14. Laurinavicius A, Hurwitz S, Rennke HG: Collapsing glomerulopathy in HIV and non-HIV patients: A clinicopath-ological and follow-up study. Kidney Int 56: 2203-2213, 1999 (Pubitemid 30004749)
15. Barisoni L, Kriz W, Mundel P, D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10: 51-61, 1999 (Pubitemid 29034942)
16. D'Agati VD: Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts). Kidney Int 73 : 399-406, 2008
17. Barisoni L, Bruggeman LA, Mundel P, D'Agati VD, Klotman PE: HIV-1 induces renal epithelial dedifferentiation in a transgenic model of HIV-associated nephropathy. Kidney Int 58: 173-181, 2000 (Pubitemid 30429862)
18. 18. Shankland SJ, Eitner F, Hudkins KL, Goodpaster T, D'Agati VD, Alpers CE: Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation. Kidney Int 58: 674-683, 2000 (Pubitemid 30620016)
19. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58: 137-143, 2000 (Pubitemid 30429858)
20. Dijkman HB, Weening JJ, Smeets B, Verrijp KC, van Kuppevelt TH, Assmann KK, Steenbergen EJ, Wetzels JF: Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int 70 : 338-344, 2006 (Pubitemid 44086583)
21. Moudgil A, Nast CC, Bagga A, Wei L, Nurmamet A, Cohen AH, Jordan SC, Toyoda M: Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 59: 2126-2133, 2001 (Pubitemid 32467604)
22. Thaunat O, Delahousse M, Fakhouri F, Martinez F, Stephan JL, Noel LH, Karras A: Nephrotic syndrome associated with hemophagocytic syndrome. Kidney Int 69: 1892-1898, 2006 (Pubitemid 43739221)
23. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, Kuhn JA, Dratch AD, D'Agati VD: Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12: 11164-11172, 2001
24. Perazella MA, Markowitz GS: Bisphosphonate nephrotoxicity. Kidney Int 74: 1385-1393, 2008
25. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD: Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11: 1439-1448, 2000 (Pubitemid 30483460)
26. Letavernier E, Bruneval P, Mandet C, Van Huyen JP, Peraldi MN, Helal I, Noel LH, Legendre C: High sirolimus levels may induce focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2: 326-333, 2007
27. Herlitz LC, Markowitz GS, Farris AB, Schwimmer JA, Stokes MB, Kunis C, Colvin RB, D'Agati VD: Development of focal segmental glomerulosclerosis after anabolic steroid abuse. J Am Soc Nephrol 21: 163-172, 2010
28. Stein DF, Ahmed A, Sunkhara V, Khalbuss W: Collapsing focal segmental glomerulosclerosis with recovery of renal function: An uncommon complication of interferon therapy for hepatitis C. Dig Dis Sci 46: 530-535, 2001 (Pubitemid 32299805)
29. Bremer CT, Lastrapes A, Alper AB, Mudad R: Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia. Am J Clin Oncol 26: 262-264, 2003
30. Kanungo S, Tamirisa S, Gopalakrishnan R, Salinas-Madrigal L, Bastani B: Collapsing glomerulopathy as a complication of interferon therapy for hepatitis C infection. Int Urol Nephrol June 4, 2009 [epub ahead of print]
31. Averbuch SD, Austin HA, Sherwin SA, Antonovych T, Bunn PA, Longo DL: Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides. N Engl J Med 310: 32-35, 1984
32. Rettmar K, Kienast J, van de Loo J: Minimal change glomerulonephritis with reversible proteinuria during interferon α2A therapy for chronic myeloid leukemia. Am J Hematol 49: 355-366, 1995
33. 33. Nakao K, Sugiyama H, Makino E, Matsuura H, Ohmoto A, Sugimoto T, Ichikawa H, Wada J, Yamasaki Y, Makino H: Minimal change nephrotic syndrome developing during postoperative interferon-beta therapy for malignant melanoma. Nephron 90: 498-500, 2002 (Pubitemid 34310116)
34. Nishimura S, Miura H, Yamada H, Shinoda T, Kitamura S, Miura Y: Acute onset of nephrotic syndrome during interferon-α treatment for chronic active hepatitis C. J Gastro-enterol 37: 854-858, 2002 (Pubitemid 35385910)
35. Dizer U, Beker CM, Yavuz I, Ortatatli M, Ozguven V, Pahsa A: Minimal change disease in a patient receiving INF-α therapy for chronic hepatitis C virus infection. J Interferon Cytokine Res 23: 51-54, 2003 (Pubitemid 36308062)
36. Suresh RL, Suryati Y, Merican I: Interferon induced glomerular disease in a patient with chronic hepatitis C. Med J Malaysia 58: 594-596, 2003 (Pubitemid 38315818)
37. Kumasaka R, Nakamura N, Shirato K, Fujita T, Murakami R, Shimada M, Nakamura M, Osawa H, Yamabe H, Okumura K: Nephrotic syndrome associated with interferon-beta-1b therapy for multiple sclerosis. Clin Exp Nephrol 10: 222-225, 2006 (Pubitemid 44496895)
38. Tovar JL, Buti M, Segarra A, Majo J, Esteban R: De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection. Int Urol Nephrol 40: 539-541, 2008
39. Ault BH, Stapleton FB, Gaber L, Martin A, Roy S, Murphy SB: Acute renal failure during therapy with recombinant human gamma interferon. N Engl J Med 319: 1397-1400, 1988
40. Traynor A, Kuzel T, Samuelson E, Kanwar Y: Minimal change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma. Nephron 67: 94-100, 1994 (Pubitemid 24119476)
41. Horowitz R, Glicklich D, Sablay LB, Wiernik PH, Wadler S: Interferon-induced acute renal failure: A case report and literature review. Med Oncol 12: 55-57, 1995
42. Coroneos E, Petrusevska G, Varghese F, Truong LD: Focal segmental glomerulosclerosis with acute renal failure associated with α-interferon therapy. Am J Kidney Dis 28: 888-892, 1996 (Pubitemid 26412085)
43. Nassar GM, Pedro P, Remmers RE, Mohanty LB, Smith W: Reversible renal failure in a patient with the hypereosino-philia syndrome during therapy with alpha interferon. Am J Kidney Dis 31: 121-126, 1998 (Pubitemid 28116693)
44. Shah M, Jenis EH, Mookerjee BK, Schriber JR, Baer MR, Herzig GP, Wetzler M: Interferon-alpha-associated focal segmental glomerulosclerosis with massive proteinuria in patients with chronic myeloid leukemia following high dose chemotherapy. Cancer 83: 1938-1946, 1998 (Pubitemid 28503725)
45. Dressler D, Wright JR, Houghton JB, Kalra PA: Another case of focal segmental glomerulosclerosis in an acutely uraemic patient following interferon therapy. Nephrol Dial Transplant 14: 2049-2050, 1999 (Pubitemid 29358921)
46. Willson RA: Nephrotoxicity of interferon alpha-ribavirin therapy for chronic hepatitis C. J Clin Gastroenterol 35: 89-92, 2002 (Pubitemid 34663358)
47. Couto CA, Faria LC, Ribeiro DD, de Paula Farah K, de Melo Couto OF, de Abreu Ferrari TC: Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C. Liver Int 26: 1294-1297, 2006
48. Isaacs A, Lindenmann J: Viral interference: I. The interferon. Proc R Soc Lond B Biol Sci 147: 258-267, 1957
49. King TE, Albera C, Bradford WZ, Costabel U, Hormel P, Lancaster L, Noble PW, Sahn SA, Szwarcberg J, Thomeer M, Valeyre D, du Bois RM: Effects of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): A multicentre, randomized, placebo-controlledtrial. Lancet 374: 222-228, 2009
50. Jadoul M, Piessevaux H, Ferrant A, Cosyns JP, van Ypersele de Strihou C: Renal thrombotic microangiopathy in patients with chronic myelogenous leukaemia treated with interferon-alpha 2b. Nephrol Dial Transplant 10: 111-113, 1995
51. Fahal IH, Murry N, Chu P, Bell GM: Acute renal failure during interferon therapy. BMJ 306: 973, 1993 (Pubitemid 23100020)
52. 52. Selby P, Kohn J, Raymond J, Judson I, McElwain T: Nephrotic syndrome during treatment with interferon. BMJ 290: 1180, 1985 (Pubitemid 15082087)
53. Rich SA, Owens TR: Inducibility of human lupus inclusions by interferons [Abstract]. J Cell Biochem [Suppl 6]: 279A, 1982
54. Feldman D, Hoar RM, Niemann WH, Valentine T, Cukierski M, Hendrickx AG: Tubuloreticular inclusions in placental chorionic villi of rhesus monkeys after maternal treatment with interferon. Am J Obstet Gynecol 155: 413-424, 1986 (Pubitemid 16054891)
55. Baudeau C, Delarue F, He CJ, Nguyen G, Adida C, Peraldi MN, Sraer JD, Rondeau E: Induction of MHC class II molecules HLA-DR, -DP, and -DQ and ICAM1 in human podocytes by gamma-interferon. Exp Nephrol 2: 306-312, 1994 (Pubitemid 24261949)
56. Kraft SW, Schwartz MM, Korbet SM, Lewis EJ: Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 16: 175-179, 2005 (Pubitemid 43073170)
57. Albaqumi M, Soos TJ, Barisoni L, Nelson PJ: Collapsing glomerulopathy. J Am Soc Nephrol 17: 2854-2863, 2006 (Pubitemid 44484675)
58. Savin VJ, Sharma M, McCarthy ET, Sharma R, Reddy S, Dong JW, Hess S, Kopp J: Cardiotrophin like cytokine-1: Candidate for the focal glomerular sclerosis permeability factor [Abstract]. J Am Soc Nephrol 19: 59A, 2008
59. Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, Jordan SC, Yap HK: Overexpression of interleukin-13 induces minimal change like nephropathy in rats. J Am Soc Nephrol 18: 1476-1485, 2007